CDK8 is a positive regulator of transcriptional elongation within the serum response network.
Journal Article
Overview
publication date
- April 1, 2010
has subject area
- Biochemical Phenomena - Protein Binding
- Biochemical Phenomena - Serum Response Element
- Biochemical Phenomena - Serum Response Element
- Biochemical Phenomena - Transcription, Genetic
- Carrier Proteins - Cyclin-Dependent Kinase 8
- Cell Cycle Proteins
- Cell Cycle Proteins - Cyclin-Dependent Kinase 8
- Cell Line - Cell Line, Tumor
- DNA-Binding Proteins - Trans-Activators
- DNA-Binding Proteins - Transcription Factor AP-1
- Gene Expression - Transcription, Genetic
- Gene Knockdown Techniques
- Genetic Structures - Serum Response Element
- Genetic Structures - Serum Response Element
- Homeodomain Proteins - Serum Response Factor
- Humans
- Metabolism - Protein Binding
- Multiprotein Complexes - Cyclin-Dependent Kinase 8
- Nuclear Proteins
- Nuclear Proteins - Cyclin-Dependent Kinase 8
- Peptides - Cyclin-Dependent Kinase 8
- Peptides - Cyclin-Dependent Kinase 8
- Proline-Directed Protein Kinases - Cyclin-Dependent Kinase 8
- Protein Interaction Mapping
- Protein-Serine-Threonine Kinases - Positive Transcriptional Elongation Factor B
- Proteins - Cyclin-Dependent Kinase 8
- Proteins - Cyclin-Dependent Kinase 8
- RNA Polymerase II
- Regulatory Elements, Transcriptional - Serum Response Element
- Regulatory Elements, Transcriptional - Serum Response Element
- Transcription Factors
- Transcription Factors - Serum Response Factor
- Transcription Factors - Trans-Activators
- Transcription Factors - Transcription Factor AP-1
- Transcriptional Elongation Factors - Positive Transcriptional Elongation Factor B
- Tumor Cells, Cultured - Cell Line, Tumor
- Viral Regulatory and Accessory Proteins - Trans-Activators
Date in CU Experts
- September 3, 2013 2:59 AM
Full Author List
- Espinosa JM; Donner AJ; Galbraith M; Taatjes D; Ebmeier C
author count
- 5
published in
- The FASEB Journal Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0892-6638
Additional Document Info
volume
- 24